Piret Fischer - Fraunhofer ISI

Piret Fischer (geb. Kukk) absolvierte ihr Studium in Molecular Diagnostics an der Tartu University, Estland, 2005 mit dem Master of Science. 2006-2007 studierte sie European Studies on Science and Technology (ESST) an der University of Maastricht, Niederlande, Abschluss: Master of Arts. 2011-2016 PhD an der Utrecht University investigating how the pharmaceutical industry markets personalised cancer medicines; title: ‘Complexities in building innovation systems: the case of radical medical technologies.

Dazwischen Forschungsaufenthalte am University College London (UK) (2004) und am CIRCLE Research Institute, Lund University (Schweden) (2007); ein Praktikum bei der Europäischen Kommission, DG Research, Directorate for Biotechnologies, Agriculture and Food/Biotechnology Unit, Brüssel (Belgien) (2006); 2007-2008 Erarbeitung der »Estonian National Biotechnology Strategy 2008-2013« als Expertin bei der Estonian Biotechnology Association, Tallin (Estland); 2009-2010 Tätigkeit als Praktikantin und wissenschaftliche Mitarbeiterin bei EuropaBio, dem Europäischen Verband der Bioindustrie in Brüssel (Belgien).

Seit 2010 wissenschaftliche Mitarbeiterin am Fraunhofer ISI, Competence Center Neue Technologien, seit Juni 2016 als Projektleiterin in den Geschäftsfeldern Innovationen im Gesundheitssystem und Bioökonomie und Lebenswissenschaften.

Alle ausklappen Alle einklappen

Forschungs- und Arbeitsgebiete
Innovationen in der Bioökonomie und den Lebenswissenschaften sowie im Gesundheitswesen

Potentialanalysen, Markt- und Foresight-Studien

Thematische Schwerpunkte: industrielle und medizinische Biotechnologie, Biomedizin, Personalisierte Medizin, medizinische Diagnostik, Strukturen des Gesundheitssystems
Projekte
Join4ATMP

Shaping the future bioeconomy across sectoral, governmental and geographical levels (Shaping-Bio)

CTCelect - Clinical Validation of an automated system for the isolation of individual circulating tumor cells from patient blood. Innovation supporting analyses on framework conditions, user requirements and market potentials

Graphene Flagship

Support to Research and Innovation Policy for Bio-based Products (BIO-SPRI)
Vorträge
EU-SPRI Forum Conference Management of Innovation Policies (2014)

EU-SPRI Forum Conference Management of Innovation Policies (2013)

Final Workshop DBF & ERACEP CSAs

Inaugural World Interdisciplinary Network for Institutional Research (WINIR) Conference (2014)
Publikationen (Auswahl)
Hüsing, Bärbel; Aichinger, Heike; Fischer, Piret (2022): Bakteriophagen in der Land- und Lebensmittelwirtschaft. Anwendungsperspektiven, Sicherheits- und Regulierungsfragen. Karlsruhe: Fraunhofer-Institut für System- und Innovationsforschung ISI

Fischer, Piret; Reiss, Thomas; Mahlich, Jörg; Gicquel, Erwan; Aichinger, Heike; Pullmann, Liliya; Bratan, Tanja (2023): Unlocking the value of innovative medicines: Insights from the advanced therapy medicinal products (ATMP) innovation systems in Germany and Sweden. In: Health Policy and Technology, 12 (2), ISSN 2211-8837. Online available (pre-proof version): https://www.sciencedirect.com/science/article/pii/S2211883723000229?via%3Dihub

Kukk Fischer, Piret ; Hekkert, M.P.; Hüsing, B.; Moors, E.H.M. (2022): Individual versus collective strategies in system building - The case of point-of-care diagnostics in Germany. In: Technological Forecasting & Social Change 177, 121474. Online available: https://authors.elsevier.com/c/1eRv898SGssg-

Bratan, T.; Fischer, P.; Maia, M.; Aschmann, V. (2020): Implementation of the UN Convention on the Rights of Persons with Disabilities: A Comparison of Four European Countries with Regards to Assistive Technologies. Societies 2020, 10(4), p. 74. Online available: https://doi.org/10.3390/soc10040074

Moors, Ellen H.M., Kukk Fischer, Piret, Boon, Wouter P.C., Schellen, Frank & Negro, Simona O. (2018). Institutionalisation of markets: The case of personalised cancer medicine in the Netherlands. In: Technological Forecasting and Social Change 128, pp. 133-143.

Kukk, Piret, Moors, Ellen H.M. & Hekkert, Marko P. (2016). Institutional power play in innovation systems: The case of Herceptin®. In: Research Policy 45 (8), pp. 1558-1569.

Kukk, P., Moors, E.H.M. & Hekkert, M.P. (2015). The complexities in system building strategies — The case of personalized cancer medicines in England. In: Technological Forecasting and Social Change 98 (0), pp. 47-59.

Kukk, P. (2013): Speeding up the Development and Implementation of Personalized Cancer Therapeutics - the case of Herceptin® in England, Conference Paper for the EU-SPRI Forum Conference 2013.

Kukk, P., Hüsing, B. (2011): “Privacy, data protection and policy implications in whole genome sequencing”. In: Est van, R., Stemerding, D. (Eds.) Making Perfect Life. Bio-engineering (in) the 21st Century. Deliverable No. 5 of the STOA Project "Making Perfect Life", STOA, European Parliament.

Kukk, P., Hüsing, B., Friedewald, M. (2011): Privacy, data protection and policy issues in next generation DNA sequencing technologies. In: Finn, R., Wright, D. (Eds.) Deliverable D2 : Deliverable D2: Privacy, data protection and ethical issues in new and emerging technologies: five case studies. Karlsruhe: Fraunhofer ISI.

Est van, R., Stemerding, D., Kukk, P. et al. (2012):Making Perfect Life. European Governance Challenges in 21st Century Bio-engineering. European Parliament, STOA report.

Reiß, T., Vignola-Gagné, E., Kukk, P. (2013): Thematische Schwerpunktbildung in den Life Sciences durch systemimmanente Prozesse. Stuttgart: Fraunhofer ISI.

Reiß, T., Vignola-Gagné, E., Kukk, P., et. al. (2013): ERACEP – Emerging Research Areas and their Covergae by ERC-Supported Projects. Final Report. European Research Council.

Publikationen (ausführliche Liste)

Jahr Year	Titel/Autor:in Title/Author	Publikationstyp Publication Type
2024	Unlocking the value and transitional purpose of plant-based meat alternative companies in the German market Schwarz, Alexander; Fischer, Piret; Weinrich, Ramona	Zeitschriftenaufsatz Journal Article
2023	Unlocking the value of innovative medicines: Insights from the advanced therapy medicinal products (ATMP) innovation systems in Germany and Sweden Fischer, Piret; Reiß, Thomas; Mahlich, Jörg; Gicquel, Erwan; Aichinger, Heike; Pullmann, Liliya; Bratan, Tanja	Zeitschriftenaufsatz Journal Article
2022	Individual versus collective strategies in system building - The case of point-of-care diagnostics in Germany Fischer, Piret; Hekkert, Marko P.; Hüsing, Bärbel; Moors, Ellen H.M.	Zeitschriftenaufsatz Journal Article
2022	Bakteriophagen in der Land- und Lebensmittelwirtschaft Hüsing, Bärbel; Aichinger, Heike; Fischer, Piret	Bericht Report
2021	Potenzialanalyse und Roadmapping Biointelligenz für Baden-Württemberg Wydra, Sven; Hüsing, Bärbel; Aichinger, Heike; Reiß, Thomas; Pullmann, Liliya; Fischer, Piret; Schwarz, Alexander; Kempter-Regel, Brigitte; Kindervater, Ralf	Bericht Report
2021	Life and biological sciences and technologies as engines for bio-based innovation Wydra, Sven; Hüsing, Bärbel; Aichinger, Heike; Fischer, Piret; Kaufmann, Tanja; Schmoch, Ulrich; Voglhuber-Slavinsky, Ariane; Bas, Davidis; Spekreijse, Jurjen; Vis, Martijn; Bardellini, Marcello; Bertuzzi, Niccolò; Moreschi, Raffaella; Ferrari, Alice de; Abbondanti Sitta, Ilaria	Bericht Report
2021	Advanced technologies for industry - Product watch. Lightweight materials Fischer, Piret	Bericht Report
2020	Implementation of the UN convention on the rights of persons with disabilities: A comparison of four European countries with regards to assistive technologies Bratan, Tanja; Fischer, Piret; Maia, Maria; Aschmann, Vera	Zeitschriftenaufsatz Journal Article
2018	Deliverable D 6.6: Final Conference report Wydra, Sven; Hüsing, Bärbel; Pullmann, Liliya; Fischer, Piret	Bericht Report
2018	Institutionalisation of markets: The case of personalised cancer medicine in the Netherlands Moors, Ellen H.M.; Kukk Fischer, Piret; Boon, Wouter; Schellen, Frank; Negro, Simona O.	Zeitschriftenaufsatz Journal Article
2018	Deliverable D 2.2: PROGRESS value chain analysis Wydra, Sven; Hüsing, Bärbel; Jäger, Angela; Lerch, Christian; Pullmann, Liliya; Fischer, Piret	Bericht Report
2018	Deliverable D 5.1: R&D&I needs in six IB value chains Hüsing, Bärbel; Fischer, Piret	Bericht Report
2017	PROGRESS. Priorities for Addressing Opportunities and Gaps of Industrial Biotechnology for an Efficient Use of Funding Resources Wydra, Sven; Hüsing, Bärbel; Fischer, Piret; Jäger, Angela; Horvat, Djerdj	Buch Book
2017	Deliverable D 1.2: Identification and description of IB innovation potential (current and future) Aichinger, Heike; Kukk, Piret; Reiß, Thomas	Bericht Report
2016	Complexities in building innovation systems Kukk, Piret	Dissertation Doctoral Thesis
2016	Study on EU positioning: An analysis of the international positioning of the EU using revealed comparative advantages and the control of key technologies. Final report Reiß, Thomas; Frietsch, Rainer; Schubert, Torben; Kukk, Piret; Velde, Els van de	Studie Study
2016	Study on EU positioning: An analysis of the international positioning of the EU using revealed comparative advantages and the control of key technologies. Annex Reiß, Thomas; Frietsch, Rainer; Schubert, Torben; Kukk, Piret; Velde, Els van de	Studie Study
2016	Institutional power play in innovation systems: The case of Herceptin® Kukk, Piret; Moors, Ellen H.M.; Hekkert, Marko P.	Zeitschriftenaufsatz Journal Article
2015	The complexities in system building strategies - the case of personalized cancer medicines in England Kukk, Piret; Moors, E.H.M.; Hekkert, Marko P.	Zeitschriftenaufsatz Journal Article
2015	Monitoring the Evolution and Benefits of Responsible Research and Innovation (MoRRI). Progress report D5.1. Update of the literature review (Sub-task 6.1) & Visioning exercise (Sub-task 6.2) Kukk, Piret; Lindner, Ralf; Warnke, Philine; Bierwisch, Antje; Bührer, Susanne; Costas, Rodrigo; Fan, Cheng; Goos, Kerstin; et al.	Bericht Report
2014	Innovations- und Technikanalyse Synthetische Biologie - SynBio Gleich, Armin von; Giese, Bernd; Königstein, Stefan; Pade, Christian; Wigger, Henning; Schmidt, Jan C.; Reiß, Thomas; Kukk, Piret; Doren, Davy van	Bericht Report
2013	Thematische Schwerpunktbildung in den Life Sciences durch systemimmanente Prozesse Reiß, Thomas; Vignola-Gagné, Etienne; Kukk, Piret	Buch Book
2012	Making Perfect Life Est, Rinie van; Stemerding, Dirk; Kukk, Piret; Hüsing, Bärbel; Keulen, Ira van; Schuijff, Mirjam; Böhle, Knud; Coenen, Christopher; Decker, Michael; Rader, Michael; Torgersen, Helge; Schmidt, Markus	Studie Study
2011	Synthetische Biologie in Baden-Württemberg: Status-quo und zukünftige Entwicklungspotenziale Reiß, Thomas; Kukk, Piret	Studie Study
2011	PRESCIENT. Privacy and emerging fields of science and technology: Towards a common framework for privacy and ethical assessment. Deliverable D2 Finn, Rachel; Friedewald, Michael; Gellert, Raphael; Gutwirth, Serge; Hüsing, Bärbel; Kukk, Piret; Mordini, Emilio; Schütz, Philip; Venier, Silvia; Wright, David	Bericht Report
2010	Analyse des Handlungsbedarfs für das Bundesministerium für Wirtschaft und Technologie (BMWi) aus der Leitmarktinitiative (LMI) der EU-Kommission für biobasierte Produkte außerhalb des Energiesektors Wydra, S.; Hüsing, B.; Kukk, P.	Studie Study

Diese Liste ist ein Auszug aus der Publikationsplattform Fraunhofer-Publica

This list has been generated from the publication platform Fraunhofer-Publica

Dr. Piret Fischer

Forschungs- und Arbeitsgebiete

Projekte

Vorträge

Publikationen (Auswahl)

Publikationen (ausführliche Liste)

Contact Press / Media

Dr. Piret Fischer